- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 10th, 2004
Research and Markets has announced the addition of Nanobiotechnology: Opportunities and Technical Analysis to their offering.
Several industries are hindered by the limitations of current technologies. In medicine, clinical diagnostics are often costly and time-consuming. Additionally, most therapeutics lack specificity, and therefore are limited in efficacy and safety. In life science research, the drug discovery process continues to be slowed by existing imaging and screening techniques. Nanobiotechnology promises to provide novel tools and materials that address current technological limitations, and thereby holds great promise for significant advances in both medicine and life science research.
|Related News Press|
Nanoscale Trojan horses treat inflammation May 24th, 2016
Programmable materials find strength in molecular repetition May 23rd, 2016
Attosecond physics: A switch for light-wave electronics May 24th, 2016